English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2537186      線上人數 : 238
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋


    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/5995


    題名: Dexamethasone透過MKP-1訊息傳遞路徑抑制人類惡性神經膠質瘤細胞的侵襲性
    Dexamethasone Inhibits Cell Invasion of Human Malignant Glioma Cells via MKP-1
    作者: 陶曉怡
    Hsiao-Yi Tao
    貢獻者: 細胞及分子生物研究所
    關鍵詞: 膠質瘤
    侵襲性
    訊息傳遞
    內生性
    膠質瘤
    dexamethasone
    MK-1
    invasion
    日期: 2005
    上傳時間: 2009-09-11 15:50:07 (UTC+8)
    摘要: Dexamethasone已經知道可以抑制癌細胞的侵襲性，但是其中的機制還不清楚。本研究探討人類惡性神經膠質瘤細胞中dexamethasone抑制細胞侵襲性的機制。人類惡性神經膠質瘤細胞具有內生性MMP-2的活性，且其活性與細胞的惡性度有關。p38 MAPK的抑制劑SB203580與p42/44 ERK的抑制劑PD98059都可以降低人類惡性神經膠質瘤細胞U87MG中MMP-2的活性。Dexamethasone可以誘發U87MG細胞中MKP-1的表現，所誘發的MKP-1隨著dexamethasone濃度的增加而增加，並隨著時間的增加而持續性表現。轉錄作用的抑制劑
    actinomycin D與轉譯作用的抑制劑cyclohexamide都可以阻斷U87MG細胞中dexamethasone所誘發MKP-1的表現，顯示dexamethasone所誘發MKP-1的表現是經由新蛋白的合成。RU486 (糖皮質激素受體拮抗劑)與triptolide (MKP-1阻斷劑)都可以降低U87MG細胞中dexamethasone所誘發的MKP-1，RU486可以逆轉dexamethasone所抑制的細胞侵襲性。NO donor sodium nitroprusside (SNP)可以逆轉U87MG細胞中dexamethasone所抑制MMP-2的活性。Triptolide可以逆轉U87MG細胞dexamethasone所抑制iNOS的活性。綜合以上結果可以得知，在U87MG細胞中，dexamethasone透過誘發MKP-1而抑制iNOS的表現及NO的釋出，進而抑制MMP-2的活性與細胞侵襲性。
    Dexamethasone has been shown to inhibit tumor invasion, however,
    the underneath mechanisms have not been elucidated. In the present study, we investigated the mechanism of which dexamethasone regulated the invasion in human malignant glioma cells. We found that human malignant glioma cells constitutively expressed MMP-2, which is well correlated with their malignancies. Treatment of glioma cells with SB203580 (a p38 MAPK inhibitor) or PD98059 (a p42/44 ERK inhibitor) reduced MMP-2 activity. Incubation of human malignant glioma cells with dexamethasone resulted in a dose- and time-dependent induction of a dual specific MAPK phosphatase, MAPK phosphatase-1(MKP-1). Treatment of glioma cells with actinomycin D (a transcription inhibitor) or cyclohexamide (a translation inhibitor) before the addition of dexamethasone decreased MKP-1 protein level, suggesting dexamethasone-induced MKP-1 expression required de novo protein synthesis. Pretreatment of cells with RU486 (a glucocorticoid receptor antagonist) or triptolide (a pharmacological MKP-1 blocker) reversed the inhibition of MMP-2 activity and cell invasion by dexamethasone. Treatment of glioma cells with NO donor, sodium nitroprusside (SNP), reversed the inhibition of MMP-2 activity by dexamethasone. In addition, pretreatment of triptolide reversed dexamethasone-reduced inducible nitric oxide synthase (iNOS) expression. Taken together, our data suggest that dexamethasone may inhibit tumor cell invasion and MMP-2 activity through MKP-1 induction, and that NO is the positive regulator of MMP-2 in human malignant glioma cells.
    資料類型: thesis
    顯示於類別:[醫學科學研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc28KbMicrosoft Word183檢視/開啟
    摘要.pdf56KbAdobe PDF316檢視/開啟
    摘要.ppt119KbMicrosoft Powerpoint234檢視/開啟
    摘要.ps482KbPostscript101檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice

    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏，包含體系內各式學術著作及學術產出。秉持開放取用的精神，提供使用者進行資料檢索、下載與取用，惟仍請適度、合理地於合法範圍內使用本平台之內容，以尊重著作權人之權益。商業上之利用，請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台，視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例，並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者，煩請權利人通知本平台維護人員([email protected])，將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋